Darci R. Block, PhD DABCC

Dr. Block is the co-medical director of the Central Clinical Laboratory and Laboratory Services at the Mayo Clinic in Rochester, MN.

Graham Segal MD

Dr. Segal attended the University of Texas at Austin. He earned his M.D. from the University of Texas Medical School at San Antonio. He completed a residency in Clinical Pathology at Baylor College of Medicine, Houston and a residency in Family Medicine at the University of Texas Health Science Center, Houston.  He is board certified in both Clinical Pathology and Family Medicine and cares for patients at Memorial Hermann TMC.

Dr. Segal also serves as the Assistant Director of the Family Medicine Clerkship at McGovern Medical School. He is actively involved in teaching medical students and residents and has won various teaching awards.  He maintains memberships in in the Harris County Medical Society, the Texas Medical Association, the American Academy of Family Physicians and the Society of Teachers of Family Medicine.

Dr. Vincent De Guire

Dr. De Guire is a clinical biochemist at Maisonneuve-Rosemont Hospital in Montreal.  He is the President of the Quality Improvement Committee of the Société Québécoise de Biologie Clinique and a member of the Working Group for Laboratory Errors and Patient Safety of the IFCC.  Dr. De Guire is also co-founder and head of clinical affairs of Nanogenecs, a Montreal-Boston startup developing a new blood-based platform for monitoring of chronic diseases. 

Dr. Hans Frykman

Dr. Frykman received his PhD at the Royal Institute of Technology and his MD at Karolinska Institute, both in Stockholm.  He was part of the discovery teams of Victoza (Novo Nordisk) and Prilosec (Astra Zeneca).  He  received postgraduate education at Karolinska University Hospital, Mayo Clinic, University of Minnesota, memorial Sloan Kettering, and UBC.  Presently he is the medical director of UBC Diagnostic Services Lab and Neurocode Labs.

Tracy Stockley, PhD

Dr. Stockley is Director of Genome Diagnostics at University Health Network, and in this role oversees the Advanced Molecular Diagnostics Laboratory at the Princess Margaret Cancer Centre and the Genome Diagnostics Clinical Laboratory at Toronto General Hospital.  Dr. Stockley is an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.  Dr. Stockley has an interest in implementation of new genomic methods for clinical laboratory use, and in quality improvement related to high-complexity laboratory testing.

Ronald A. Booth, PhD, FCACB

Dr. Booth is an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa and Clinical Biochemist at the Ottawa Hospital where he directs the Immunology Section of the EORLA regional laboratory. He is the Medical Laboratory Director for the Cornwall Community Hospital laboratory and a clinical biochemistry consultant for the Queensway Carleton Hospital.

His expertise in laboratory diagnostics has provided the opportunity to sit as an expert member of the Health Technology Expert Review Panel (HTERP) for the Canadian Agency for Drugs and Technologies in Health (CADTH) and as a scientific member, and current the Vice-Chair, of the Institute for Quality Management in Healthcare (IQMH) Endocrinology & Immunology Scientific Committee. He was the Treasurer of the Canadian Society of Clinical Chemists (CSCC) from 2008 to 2014, and current president of the Ontario Society of Clinical Chemists (OSCC). 

Trefor Higgins

Trefor Higgins was born in the United Kingdom and received degrees from universities in the United Kingdom and Canada.  He worked for many years in the community laboratory sector in Alberta and retired in June 2017.  However he was persuaded to become interim zone director for Clinical Biochemistry for the Edmonton Zone, a position he currently holds.  He has authored over 200 articles/abstracts and has lectured on every continent.  He has received numerous awards including the CSCC Award for Outstanding Contribution to Clinical Biochemistry.

Dr. Janet Simons

Dr. Janet Simons is dual certified as a medical biochemist and internist. She splits her clinical time between inpatient internal medicine and laboratory medicine work. In both roles, her focus is on delivering efficient and effective patient centered care. Using the R programming language, Dr. Simons has developed multiple tools to leverage large laboratory data sets to identify areas for improvement in the way physicians and laboratories work together to ensure the right patient gets the right result for right test at the right time.

Dr. Kelly Doyle, PhD, D(ABCC), FAACC

Dr. Kelly Doyle is a fellow in the American Association of Clinical Chemistry. He is a board certified clinical chemist at Intermountain Medical Center and Primary Children’s Hospital and serves as adjunct faculty at the University of Utah School of Medicine. His interests involve the clinical application of mass spectrometry, pediatrics, toxicology, and laboratory best practice.

Dr. Kika Veljkovic, MD, PhD

Kika completed her Clinical Biochemistry Fellowship at McMaster University, after earning an MD degree from University of Belgrade, Serbia, and a PhD from McMaster. During training, she received major funding and awards from CIHR, Heart and Stroke Foundation of Canada, CSCC and AACC. Kika's publications include first-author papers in Blood and Clinical Biochemistry, and she has presented at national and international conferences. Kika is an Adjunct Clinical Professor at McMaster University.
As a clinical biochemist at LifeLabs, Kika’s daily work focuses on high volume chemistry and immunoassays. She is involved in multiple projects, including leadership in identification, evaluation, and implementation of new technologies. Her current professional involvement is with IQMH, as a vice chair of the Endocrinology and Immunology Scientific Committee.

Dr. Danijela Konforte, PhD, FCACB

Danijela joined LifeLabs as a clinical biochemist in 2012 and also became the laboratory director for the Sudbury LifeLabs location in 2014. She supports provincial routine chemistry and urinalysis testing and has a special interest in clinical toxicology testing as well as mass spectrometry-based method development and validation.

Dr. Konforte holds PhD in Immunology from the University of Toronto, where she also completed a clinical chemistry fellowship. In 2013 she became a Fellow of the Canadian Academy of Clinical Biochemistry. She is a member of the Institute for Quality Management in Healthcare (IQMH) Chemistry Scientific Committee, and also serves as a Councillor for the CSCC and Associate Editor of CSCC Newsletter. Danijela is the author or co-author of 12 peer-reviewed articles.

Dr. Julie Shaw

Julie Shaw is the Division Head for Biochemistry and the Director for POCT at The Ottawa Hospital and the Eastern Ontario Regional Laboratories Association (EORLA).  She is also an Assistant Professor in the Department of Pathology and Laboratory Medicine at The University of Ottawa.  Dr. Shaw completed her PhD in Laboratory Medicine and Pathobiology at the University of Toronto as well as her Fellowship in Clinical Biochemistry.  Dr. Shaw's research interests are related to quality assurance best practices for POCT and the use of POCT glucose data to monitor effectiveness of initiatives aimed at improving glycemic control in hospitalized patients.

Dr. Allison Venner

Dr. Allison Venner works as a Clinical Biochemist and is the Provincial POCT Medical Lead with Alberta Public Laboratories. She is also a Clinical Assistant Professor in the Department of Pathology & Lab Medicine, University of Calgary. She completed her interdisciplinary Ph.D. degree (Faculty of Kinesiology and Dept. of Medical Science) at the University of Calgary and her Postdoctoral Fellowship Diploma in Clinical Chemistry at the University of Toronto. She previously worked at the Red Deer Regional Hospital as the Central Zone Clinical Biochemist with Alberta Health Services for over 5 years, and was an Assistant Clinical Professor with the Department of Laboratory Medicine, University of Alberta. Dr. Venner greatly enjoys teaching, and she is particularly interested in the area of POCT and clinical laboratory quality management. 

Brad Urquhart, PhD

Brad Urquhart did his undergraduate and PhD degrees in Pharmacology and Toxicology at Western University. He completed post-doctoral training at Vanderbilt University and Western University in Clinical Pharmacology. He started at Western University as an Assistant Professor in the Department of Physiology and Pharmacology in 2009 and was promoted to Associate Professor in 2015. His lab uses mass spectrometry based metabolomics to study why patients respond differently to drugs and to identify new biomarkers of kidney disease. 

Jason Robinson

Jason is currently Chief Fellow of Clinical Biochemistry at the University of Calgary and Alberta Public Laboratories.  Prio to Calgary, Jason spent 2 years as a postdoc at Baylor College of Medicine working in Pediatric gastroenterology.  Jason received his PhD from Memorial University of Newfoundland focusing in the area of Nutritional Biochemistry.

Jennifer Taher

Jennifer Taher is a second-year clinical biochemistry fellow at the University of Toronto (UofT).  She completed her Bachelor of Science in Cell and Molecular Biology and a Ph.D. in Laboratory Medicine and Pathobiology at UofT, with a focus on diabetes and lipid research.  Jennifer has a particular interest in test utilization initiatives and big data analytics.  She is currently working on a reflexive testing algorithm at St. Michael's Hospital and an audit and feedback initiative at St. Joseph's Health Center to promote appropriate laboratory test utilization.

Jake Cosme

Dr. Jake Cosme is a Second-Year Clinical Chemistry Fellow at the University of Toronto.  He completed his PhD in the Department of Physiology at the University of Toronto.  His Clinical Chemistry research interests include quality measurement using Sigma metrics, harmonization of reference intervals, and quality indicators in POC testing.

Yifei Yang

Dr. Yang is an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pharmacology from Yale University and subsequently completed a postdoctoral fellowship in clinical chemistry at the University of Chicago Medicine. She is a diplomate of the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. Dr. Yang’s clinical and research interests are focused on developing and validating new diagnostic assays in therapeutic drug monitoring and proteomics biomarkers. 

Ajay Rajaram

Ajay Rajaram is an internationally trained physician with a doctorate in biomedical engineering from the University of Saskatchewan. His doctorate research was on the application of 3D bioprinting towards repair of peripheral nerve injury. He is passionate about pathology and regenerative medicine and is currently a postdoctoral fellow in the regenerative medicine program at OHRI.